News FDA grants fast review for Roche's haemophilia drug Emicizumab is firm's latest blockbuster hopeful
News Shire injunction blocks Roche's 'misleading' statements on h... Shire alleges trial info "unlawfully disparages" its product.
News Patient death raises concerns over Roche haemophilia drug Concerns following event on HAVEN1 trial.
News Spark reassures on safety of haemophilia gene therapy Study of nine patients produce encouraging results
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
